Literature DB >> 24357273

Cancer immunotherapy.

Marcia McNutt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24357273     DOI： 10.1126/science.1249481

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  42 in total

Review 1.  Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.

Authors:  Atsushi Yonezawa; Suparna Dutt; Cariad Chester; Jeewon Kim; Holbrook E Kohrt
Journal:  Clin Cancer Res       Date:  2015-04-23       Impact factor: 12.531

Review 2.  Intratumoral dendritic cells in the anti-tumor immune response.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2015-01-19       Impact factor: 11.530

Review 3.  Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.

Authors:  Yi-Gang Wang; Pan-Pan Huang; Rong Zhang; Bu-Yun Ma; Xiu-Mei Zhou; Yan-Fang Sun
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Pre-treatment neutrophils count as a prognostic marker to predict chemotherapeutic response and survival outcomes in glioma: a single-center analysis of 288 cases.

Authors:  Zhiliang Wang; Liyun Zhong; Guanzhang Li; Ruoyu Huang; Qiangwei Wang; Zheng Wang; Chuanbao Zhang; Baoshi Chen; Tao Jiang; Wei Zhang
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

Review 5.  Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.

Authors:  Sijin Guo; Congcong Xu; Hongran Yin; Jordan Hill; Fengmei Pi; Peixuan Guo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-08-27

6.  Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors.

Authors:  Yanping Wu; Lianjun Lin; Xinmin Liu
Journal:  Dis Markers       Date:  2020-06-09       Impact factor: 3.434

7.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

Review 8.  Immunotherapeutic advances in gastric cancer.

Authors:  Akira Yoneda; Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2021-02-15       Impact factor: 2.549

9.  Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria.

Authors:  Wenguang Wang; Haiheng Xu; Qingsong Ye; Feng Tao; Ian Wheeldon; Ahu Yuan; Yiqiao Hu; Jinhui Wu
Journal:  Nat Biomed Eng       Date:  2022-01-20       Impact factor: 29.234

10.  Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.

Authors:  Shaowen Li; Chunli Dong; Jiayan Chen; Xiaocui Gao; Xiuying Xie; Xin Zhang
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.